Capasso, Anna
 Distribuzione geografica
Continente #
NA - Nord America 1.431
AS - Asia 1.033
EU - Europa 917
SA - Sud America 205
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 32
OC - Oceania 3
Totale 3.682
Nazione #
US - Stati Uniti d'America 1.354
SG - Singapore 453
IT - Italia 358
CN - Cina 207
BR - Brasile 159
VN - Vietnam 129
FR - Francia 104
DE - Germania 84
IE - Irlanda 69
SE - Svezia 60
FI - Finlandia 49
JP - Giappone 44
CA - Canada 43
GB - Regno Unito 43
IN - India 40
HK - Hong Kong 38
NL - Olanda 32
PL - Polonia 28
ID - Indonesia 25
BD - Bangladesh 21
KR - Corea 21
MX - Messico 19
AR - Argentina 18
ES - Italia 18
CZ - Repubblica Ceca 15
RU - Federazione Russa 13
ZA - Sudafrica 10
AT - Austria 9
PK - Pakistan 8
TR - Turchia 8
EC - Ecuador 7
CH - Svizzera 6
CO - Colombia 6
IQ - Iraq 6
LT - Lituania 6
CR - Costa Rica 5
MA - Marocco 5
PH - Filippine 5
PY - Paraguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
SA - Arabia Saudita 4
UA - Ucraina 4
UZ - Uzbekistan 4
BE - Belgio 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BT - Bhutan 2
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
ME - Montenegro 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
UY - Uruguay 1
Totale 3.621
Città #
Singapore 273
Ashburn 188
San Jose 187
Rome 123
Dublin 65
New York 65
Los Angeles 56
Hefei 51
Tokyo 44
Ho Chi Minh City 42
Hong Kong 38
Beijing 36
Milan 36
Hanoi 33
Dallas 32
Helsinki 30
Lauterbourg 28
Munich 27
Chandler 26
Frankfurt am Main 25
Boardman 23
Jakarta 23
Orem 21
Santa Clara 21
Warsaw 21
Buffalo 20
Seoul 20
Atlanta 17
Kent 16
Montreal 16
The Dalles 16
São Paulo 14
Paris 13
Boston 12
Brno 12
Chennai 12
Poplar 12
Denver 11
London 11
Toronto 11
Stockholm 10
Amsterdam 9
Council Bluffs 9
Da Nang 9
Lappeenranta 9
Phoenix 9
Houston 8
Memphis 8
Nuremberg 8
Palermo 8
Chicago 7
Düsseldorf 7
Mexico City 7
Mumbai 7
Brescia 6
Brooklyn 6
Marseille 6
Turku 6
Curitiba 5
Haiphong 5
Hangzhou 5
Johannesburg 5
Moscow 5
Roubaix 5
Wroclaw 5
Baku 4
Brasília 4
Florence 4
Fortaleza 4
Gustavo Adolfo Madero 4
Las Vegas 4
Londrina 4
Marília 4
Pune 4
San Francisco 4
San José 4
Seattle 4
Tashkent 4
Tukwila 4
Washington 4
Ahmedabad 3
Baghdad 3
Bremen 3
Caorle 3
Charlotte 3
City of London 3
Falkenstein 3
Grottaferrata 3
Guayaquil 3
Hyderabad 3
Indianapolis 3
Kazan' 3
Manchester 3
Naples 3
Princeton 3
Ribeirão Preto 3
Rio de Janeiro 3
Ronciglione 3
Santa Fe 3
Shanghai 3
Totale 2.021
Nome #
Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study 309
Assessing floppy infants: a new module 215
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 197
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 182
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 169
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 164
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 160
Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data 156
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 149
Early treatment of type II SMA slows rate of progression of scoliosis 143
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 136
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey 133
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 133
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 132
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 128
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 121
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 115
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 110
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? 108
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 102
Long term follow-up of scoliosis progression in type II SMA patients 101
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 90
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 89
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 76
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 63
Identification and treatment of neurodevelopmental and mental disorders in boys and adults with Duchenne muscular dystrophy: a cohort study 62
Italian validation of the SMA independence scale–upper limb module 41
Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study 30
Vertebral fractures and muscle function in glucocorticoid-treated individuals with Duchenne muscular dystrophy: a cohort study 18
A lethal progressive neuroinflammation disguised as MOGAD revealing a final diagnosis of Griscelli syndrome 16
Development of the “SMA NNE,” a short neonatal neurological examination for newborns with spinal muscular atrophy 14
Upper limb progression in Duchenne muscular dystrophy: Insights from a 36-month longitudinal study using the PUL 20 12
The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study 8
Totale 3.682
Categoria #
all - tutte 14.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 0 1 3 3 22
2022/2023153 14 16 4 11 5 7 20 16 14 5 15 26
2023/2024321 9 39 14 17 11 45 54 10 7 20 57 38
2024/2025713 11 8 44 37 59 42 44 26 84 57 167 134
2025/20262.066 180 78 162 284 397 120 356 102 108 111 117 51
2026/2027400 70 330 0 0 0 0 0 0 0 0 0 0
Totale 3.682